Alexandre Lebrun, a serial French entrepreneur, has been appointed to head AMI Labs, a venture-backed AI research hub. Known for selling two AI startups to Nasdaq-listed firms and leading Meta’s Paris AI lab, Lebrun now scales Nabla, an AI assistant platform for healthcare. The move signals a strategic pivot toward medical AI, with $2 million in funding securing partnerships with European healthcare providers. AMI Labs aims to bridge clinical workflows with generative AI, positioning itself as a disruptor in Europe’s healthcare tech sector.